769
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Renal Cyst Infection Caused by Brucella abortus

, , , , , & show all
Pages 302-304 | Received 25 Sep 2012, Accepted 16 Oct 2012, Published online: 26 Nov 2012

REFERENCES

  • Sklar AH, Caruana RJ, Lammers JE, Strauser GD. Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1987;10:81–88.
  • Sallee M, Rafat C, Zahar JR, . Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4:1183–1189.
  • Tsuchiya Y, Ubara Y, Suwabe T, . The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts? Clin Exp Nephrol. 2011;15:151–153.
  • Yang CC, Chuang FR, Chen JB, Lee CT, Wu CH. A potential salvage therapy for refractory renal cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2012;16:183–184.
  • Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5:2048–2056.
  • Migali G, Annet L, Lonneux M, Devuyst O. Renal cyst infection in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2008;23:404–405.
  • Fugier E, Pappas G, Gorvel JP. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev Mol Med. 2007;9:1–10.
  • Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 2009;76:149–168.
  • Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM. Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother. 1988;32:844–847.
  • Hiyama L, Tang A, Miller LG. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Am J Kidney Dis.2006;47:e9–e13.
  • Kurtaran B, Candevir A, Tasova Y, . Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors. Med Sci Monit. 2010;16:CR246–CR251.
  • Bossi P, Tegnell A, Baka A, Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill. 2004;9:E15–E16.
  • Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother. 2006;50:22–33.
  • Solis Garcia del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One. 2012;7:e32090.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.